ALX Oncology Holdings Inc. (ALXO) Stock Price

1.40 ▼ -0.09 (-6.04%)
Open: 1.48 Vol: 43.51K Day's range: 1.39 - 1.48 Dec 23, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ALXO Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 1.41▼ 1.41▼ 1.42▼ 1.44▼ 1.42▼
MA10 1.42▼ 1.44▼ 1.45▼ 1.46▼ 1.46▼
MA20 1.46▼ 1.46▼ 1.46▼ 1.42▼ 1.41▼
MA50 1.47▼ 1.47▼ 1.46▼ 1.47▼ 1.00▲
MA100 1.48▼ 1.47▼ 1.43▼ 1.35▲ 4.01▼
MA200 1.46▼ 1.42▼ 1.42▼ 0.94▲ 6.82▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.008▼ -0.009▼ -0.009▼ 0.004▲ -0.011▼
RSI 33.609▼ 38.219▼ 39.875▼ 47.694▼ 52.613▲
STOCH 7.795▼ 7.051▼ 8.035▼ 35.216     38.798    
WILL %R -96.296▼ -96.296▼ -96.296▼ -66.667     -71.311    
CCI -72.328     -100.124▼ -143.954▼ -70.063     -49.071    
Latest Filters Detected On ALXO
RSI $ALXO RSI(14) Crossed Below 50 Set Alert
MA $ALXO Price Crossed Below MA(50) Set Alert
MA $ALXO Price Crossed Below MA(26) Set Alert
MA $ALXO Price Crossed Below MA(13) Set Alert
MA $ALXO Price Crossed Below MA(7) Set Alert
CDL $ALXO Marubozu Candlestick Pattern Detected Set Alert
ALX Oncology Holdings Inc. News
ALX Oncology Holdings (ALXO) Price Target Increased by 12.50% to 3.06
Saturday, November 15, 2025 04:00 PM
The average one-year price target for ALX Oncology Holdings (NasdaqGS:ALXO) has been revised to $3.06 / share. This is an increase of 12.50% from the prior estimate of $2.72 dated November 7, 2025.
Friday 9/19 Insider Buying Report: AROC, ALXO
Friday, September 19, 2025 08:27 AM
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. At ...
ALX Oncology to Host Webcast on January 23 Discussing Updated Data from ASPEN-06 Trial of Evorpacept in HER2-Positive Gastric Cancer
Tuesday, January 21, 2025 02:10 PM
ALX Oncology will host a webcast on January 23 to discuss updated ASPEN-06 trial data for evorpacept in gastric cancer. ALX Oncology Holdings Inc. will host a virtual event on January 23 at 1:00 p.m.
ALXO historical stock data
date open high low close volume
23/12/25 1.48 1.48 1.39 1.40 43,509
22/12/25 1.49 1.53 1.45 1.49 101,423
19/12/25 1.44 1.50 1.44 1.45 131,809
18/12/25 1.48 1.56 1.40 1.41 291,336
17/12/25 1.44 1.51 1.39 1.45 220,672
16/12/25 1.38 1.50 1.37 1.43 128,733
15/12/25 1.46 1.50 1.40 1.40 222,037
12/12/25 1.51 1.5421 1.4614 1.47 96,843
11/12/25 1.54 1.55 1.50 1.52 85,627
10/12/25 1.48 1.57 1.4455 1.54 214,458
Quote Details
52wk Low:0.404
52wk High:2.27
Vol:43.51K
Avg Vol(3m):7M
1Y Chng:-20.90%
1M Chng:+6.87%
Add to Watch List
More Information
Index US Composite
Market Cap. 80.78M